Fulgent Genetics, Inc. (NASDAQ:FLGT) Q1 2026 Earnings Call Transcript
Operator: Greetings. Welcome to Fulgent Genetics First Quarter 2026 Conference Call and Webcast. [Operator Instructions] please note, this conference is being recorded.
Fulgent Genetics Inc. (FLGT)
Market is closed
Sector: Services-Medical Laboratories
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Invenomic Capital Management Ali Motamed | 610,318 | $9,704,056 | 0.45% | |
| 2. | D E Shaw D. E. Shaw | 486,770 | $7,739,643 | -31% | 0% |
| 3. | Millennium Management Israel Englander | 401,819 | $6,388,922 | -58% | 0% |
| 4. | Diametric Capital Nick Thakore | 361,046 | $5,740,631 | +81% | 1.49% |
| 5. | Two Sigma Advisors John Overdeck And David Siegel | 322,189 | $5,122,805 | +67% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $15.96 | 100,000 | $1,596,470.00 | 348,282 | 2025-03-05 | Filing | |
| $4.95 | 8,739 | $43,239.70 | 6,579,326 | 2019-03-05 | Filing | |
| $3.59 | 10,880 | $39,032.00 | 6,570,587 | 2018-11-13 | Filing | |
| $3.36 | 10,000 | $33,610.00 | 6,559,707 | 2018-11-09 | Filing | |
| $3.60 | 1,000 | $3,604.20 | 1,000 | 2017-11-30 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $17.89 | 2,146 | $38,382.28 | 367,605 | 2026-06-02 | Filing | |
| $17.89 | 1,688 | $30,190.72 | 990,374 | 2026-06-02 | Filing | |
| $17.60 | 1,201 | $21,137.60 | 369,751 | 2026-05-27 | Filing | |
| $17.60 | 945 | $16,632.00 | 992,062 | 2026-05-27 | Filing | |
| $28.33 | 1,140 | $32,298.25 | 336,749 | 2025-12-02 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 2,774,519 | $44,114,850 | 0% | |
| 2. | 1,289,000 | $20,495,100 | 0.2% | |
| 3. | 880,150 | $13,994,385 | 0% | |
| 4. | 671,664 | $10,678,638 | 0% | |
| 5. | 584,207 | $9,290,416 | 0% |
News See All
Fulgent Genetics, Inc. (NASDAQ:FLGT) Q4 2025 Earnings Call Transcript
Operator: Greetings. Welcome to Fulgent Genetics, Inc. Fourth Quarter 2025 Conference Call and Webcast. At this time, all participants are in a listen-only mode.
Fulgent Genetics, Inc. (NASDAQ:FLGT) Q3 2025 Earnings Call Transcript
Operator: Greetings, and welcome to the Fulgent Genetics Q3 2025 Conference Call and Webcast. [Operator Instructions] As a reminder, this conference is being recorded.
Fulgent Genetics, Inc. (NASDAQ:FLGT) Q2 2025 Earnings Call Transcript
Operator: Greetings, and welcome to the Fulgent Genetics Q2 2025 Conference Call and Webcast. [Operator Instructions] As a reminder, this conference is being recorded.
Fulgent Genetics, Inc. (NASDAQ:FLGT) Q1 2025 Earnings Call Transcript
Melanie Solomon: Greetings and welcome to the Fulgent Genetics, Inc. Q1 2025 Conference Call and Webcast. At this time, all participants are in a listen-only mode.
Fulgent Genetics, Inc. (NASDAQ:FLGT) Q4 2024 Earnings Call Transcript
Operator: Greetings, and welcome to the Fulgent Genetics, Inc. Q4 2024 Conference Call and Webcast. At this time, all participants are in a listen-only mode.
10 Best Genomics Stocks To Buy Right Now
Genomics is the study of genes and how they function.
Fulgent Genetics, Inc. (NASDAQ:FLGT) Q3 2024 Earnings Call Transcript
Operator: Greetings and welcome to the Fulgent Genetics Q3 2024 Conference Call and Webcast. At this time, all participants are in a listen-only mode.
Fulgent Genetics, Inc. (NASDAQ:FLGT) Q2 2024 Earnings Call Transcript
Operator: Hello and welcome to the Fulgent Genetics Q2 2024 Conference Call and Webcast. [Operator Instructions] A question-and-answer session will follow the formal presentation.
Fulgent Genetics, Inc. (NASDAQ:FLGT) Q1 2024 Earnings Call Transcript
Fulgent Genetics, Inc. beats earnings expectations. Reported EPS is $-0.01, expectations were $-0.33. Fulgent Genetics, Inc.
Hedge Fund Resource Center